RADIOMEDIX
RadioMedix, Inc. is a privately held biotechnology company focused on innovative new targeted radiopharmaceuticals for diagnosis and therapy of cancer.
RADIOMEDIX
Industry:
Biotechnology Health Care
Founded:
2006-01-01
Address:
Houston, Minnesota, United States
Country:
United States
Website Url:
http://www.radiomedix.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Content Delivery Network Google Universal Analytics Font Awesome
Similar Organizations
Origin
Origin is a privately held, clinical-stage biotechnology company.
CZ Biomed Corporation
CZ BioMed Corp. is a privately held biotechnology company.
TRIM-edicine
TRIM-edicine is an rapid growing, privately held biotechnology company
X-Chem
X-Chem, Inc. is a privately held biotechnology company.
X-Rx Inc.
X-Rx Inc. is a privately held biotechnology company
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.radiomedix.com Semrush global rank: 3.59 M Semrush visits lastest month: 4.02 K
- Host name: cloudproxy10103.sucuri.net
- IP address: 192.124.249.103
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "RadioMedix"
RadioMedix, Inc
RadioMedix, Inc. is a clinical stage biotechnology company, based in Houston, Texas, focused on innovative targeted radiopharmaceuticals for diagnosis, monitoring, and therapy of cancer. …See details»
Home Page – RadioMedix
RadioMedix, Inc. is a clinical stage biotechnology company, based in Houston, Texas, focused on innovative targeted radiopharmaceuticals for diagnosis, monitoring, and therapy of cancer. The company is commercializing …See details»
RadioMedix - Crunchbase Company Profile & Funding
RadioMedix is a privately held biotechnology company focused on innovative new targeted radiopharmaceuticals for diagnosis and therapy of cancer. A Targeted Alpha Therapy (TAT) for treating metastatic castration-resistant prostate …See details»
Radiomedix, Inc. - LinkedIn
RadioMedix, Inc. is a biotechnology company, based in Houston, Texas, focused on innovative targeted radio-pharmaceuticals for diagnosis, monitoring and therapy of cancer. The company is...See details»
Radiomedix, Inc. - The Org
RadioMedix is a privately held biotechnology company focused on innovative new targeted radiopharmaceuticals for diagnosis and therapy of cancer.See details»
Management – RadioMedix
Founder & Chairman of the Board/ CEO of RadioMedix (2006) • Board certified nuclear medicine physician • Former Deputy Chair and Chief of Clinical Nuclear Medicine MD.See details»
Sanofi, RadioMedix, and Orano Med announce licensing …
Sep 12, 2024 · As part of its effort to develop innovative treatments for people living with rare cancers, Sanofi has entered into an exclusive licensing agreement with RadioMedix, Inc., a …See details»
Sanofi and Orano join forces to develop next-generation …
Oct 17, 2024 · Sanofi and Orano Med, a subsidiary of the Orano Group and a pioneer in the development of targeted alphatherapies in oncology, have entered into an agreement to …See details»
Press Release: Sanofi, RadioMedix, and Orano Med announce …
Sep 12, 2005 · As part of its effort to develop innovative treatments for people living with rare cancers, Sanofi has entered into an exclusive licensing agreement with RadioMedix, Inc., a …See details»
RadioMedix Company Profile 2024: Valuation, Funding & Investors …
Operator of a biotechnology firm intended to focus on targeted radio-pharmaceuticals for diagnosis, monitoring, and therapy of cancer.See details»
Radio Medix and AREVA Med - SBIR NCI contract awarded to …
Nov 1, 2016 · RadioMedix, Inc. (Houston, TX) and AREVA Med (Plano, TX) announced today that they have been awarded a collaborative Small Business Innovation Research (SBIR) Contract …See details»
News - RadioMedix
Mar 25, 2024 · Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines. 225Ac-PSMA-I&T is …See details»
RadioMedix - Funding, Financials, Valuation & Investors
RadioMedix is funded by Portland Investment Counsel. Which investors participated in the most funding rounds?See details»
Radiomedix and Orano Med Announce the Initiation of the Phase …
Jan 3, 2022 · RadioMedix, Inc. is a clinical-stage biotechnology company, and sponsor of the AlphaMedix™ trial, based in Houston and Humble, Texas. The company is focused on …See details»
RadioMedix announces a $40 million Series A financing for
Oct 7, 2022 · RadioMedix is committed to the advancement of a targeted alpha therapy (TAT) pipeline and diagnostic companion radiopharmaceuticals for rare and aggressive cancers.See details»
RadioMedix announces a $40 million Series A financing for the ...
Oct 6, 2022 · Houston, Texas and Burlington, Ontario, October 6th, 2022 – RadioMedix, Inc. (“RadioMedix” or “Company”), a clinical-stage biotechnology company announced the …See details»
RadioMedix announces a $40 million Series A financing for the ...
Oct 7, 2022 · RadioMedix is committed to the advancement of a targeted alpha therapy (TAT) pipeline and diagnostic companion radiopharmaceuticals for rare and aggressive cancers.See details»
RadioMedix and Orano Med receive FDA orphan drug designation
Nov 13, 2018 · RadioMedix Inc. (a Texas-based clinical stage biotechnology company) and Orano Med (a nuclear biotechnology company) announced today that the United States Food & Drug …See details»
Sanofi, RadioMedix, and Orano Med announce licensing …
Sep 12, 2024 · About RadioMedix. RadioMedix, Inc. is a clinical-stage biotechnology company, based in Houston and Humble, Texas. The company is focused on innovative targeted …See details»
Radiomedix and Orano Med Announce the Initiation of the
Jan 3, 2022 · RadioMedix, Inc. is a clinical-stage biotechnology company, and sponsor of the AlphaMedix™ trial, based in Houston and Humble, Texas. The company is focused on …See details»